Skip to product information
1 of 1

GeneBio Systems

SLC7A11 Polyclonal Antibody

SLC7A11 Polyclonal Antibody

SKU:E-AB-17625

Regular price £423.00 GBP
Regular price Sale price £423.00 GBP
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: SLC7A11

Target Synonym: Amino acid transport system xc xCT;Amino acid transport system xc-;Calcium channel blocker resistance protein CCBR1;Calcium channel blocker resistance protein CCBR1;CCBR1;Cysteine/glutamate transporter;Cystine/glutamate transporter;OTTHUMP00000164578;SLC7A11;Solute carrier family 7 (anionic amino acid transporter light chain;xc- system);member 11;solute carrier family 7;Solute carrier family 7 member 11;Solute carrier family 7;(cationic amino acid transporter;y+ system) member 11;SYSTEM Xc(-) TRANSPORTER-RELATED PROTEIN;xCT;XCT

Research Areas: Cancer;Cell biology;Metabolism;Signal transduction

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human;Mouse

Application: IHC

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: Q9UPY5

Accession:

Background: This gene encodes a member of a heteromeric, sodium-independent, anionic amino acid transport system that is highly specific for cysteine and glutamate. In this system, designated Xc(-), the anionic form of cysteine is transported in exchange for glutamate. This protein has been identified as the predominant mediator of Kaposi sarcoma-associated herpesvirus fusion and entry permissiveness into cells. Also, increased expression of this gene in primary gliomas (compared to normal brain tissue) was associated with increased glutamate secretion via the XCT channels, resulting in neuronal cell death.

Concentration: 0.4 mg/mL

Immunogen: Synthetic peptide of human SLC7A11

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Purification method: Affinity purification

Dilution: IHC 1:20-100

Calculated MW: 55 kDa

ObservedMW:

View full details